Development of a Sustainable High-Performance Liquid Chromatography (HPLC) Method for Quantifying Metformin, Sitagliptin, and Empagliflozin in Type 2  Diabetes Treatment

Objective: To develop and validate a green, environmentally sustainable high-performance liquid chromatography (HPLC) method for the simultaneous determination of three commonly used antidiabetic agents: Metformin Hydrochloride (MET), Sitagliptin Phosphate (STG), and Empagliflozin (EMP). Study Design: Experimental analytical study. Place and Duration of Study: This study was conducted at the State Company for Drugs Industry and Medical Appliances Samarra (SDI) Iraq from April 2024 to May 2024. Methods: The chromatographic separation was achieved using an isocratic elution on a C10 column (4.6 × 250 mm, 5 µm) with a mobile phase consisting of phosphate buffer (20 mM), methanol, and acetonitrile in the ratio of 65:30:5 (v/v/v), adjusted to pH 2.9. The flow rate was maintained at 1.0 mL/min, with a column temperature of 30°C and a total run time of 15 minutes. Detection was performed using UV spectroscopy at 208 nm. Linearity was established for MET (0.08–0.13 mg/mL), STG (0.035–0.065 mg/mL), and EMP (0.014–0.026 mg/mL), with correlation coefficients exceeding 0.998 and RSD% not exceeding 1.06%. The method’s greenness was evaluated using AGREE and GAPI tools. Additionally, the Blue Applicability Grade Index (BAGI) was employed to assess operational and environmental suitability. Results: The method exhibited high accuracy, reproducibility, and compliance with green analytical chemistry standards. The AGREE and GAPI assessments confirmed the method's minimal environmental impact. BAGI scoring yielded a value of 82.5, indicating strong sustainability and applicability. The method was successfully applied to the analysis of 13 commercial antidiabetic products, including branded and generic formulations available in the Iraqi market. Conclusion: The developed HPLC method provides a reliable, accurate, and environmentally sustainable approach for the simultaneous analysis of MET, STG, and EMP. It demonstrates strong analytical performance and practical utility, contributing to green pharmaceutical quality control and sustainable laboratory practices.

Authors

Publication Details

Journal
Medical Forum Monthly
Published
2025-04-12
DOI
https://doi.org/10.60110/medforum.360304
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a Sustainable High-Performance Liquid Chromatography (HPLC) Method for Quantifying Metformin, Sitagliptin, and Empagliflozin in Type 2  Diabetes Treatment

Eman Thiab A Al Samarrai, Mahmood Shakir Al Samarrai
Medical Forum Monthly
Diabetes Treatment and Management
article

Development of a Sustainable High-Performance Liquid Chromatography (HPLC) Method for Quantifying Metformin, Sitagliptin, and Empagliflozin in Type 2  Diabetes Treatment

Eman Thiab A Al Samarrai, Mahmood Shakir Al Samarrai
article en

Abstract

Objective: To develop and validate a green, environmentally sustainable high-performance liquid chromatography (HPLC) method for the simultaneous determination of three commonly used antidiabetic agents: Metformin Hydrochloride (MET), Sitagliptin Phosphate (STG), and Empagliflozin (EMP). Study Design: Experimental analytical study. Place and Duration of Study: This study was conducted at the State Company for Drugs Industry and Medical Appliances Samarra (SDI) Iraq from April 2024 to May 2024. Methods: The chromatographic separation was achieved using an isocratic elution on a C10 column (4.6 × 250 mm, 5 µm) with a mobile phase consisting of phosphate buffer (20 mM), methanol, and acetonitrile in the ratio of 65:30:5 (v/v/v), adjusted to pH 2.9. The flow rate was maintained at 1.0 mL/min, with a column temperature of 30°C and a total run time of 15 minutes. Detection was performed using UV spectroscopy at 208 nm. Linearity was established for MET (0.08–0.13 mg/mL), STG (0.035–0.065 mg/mL), and EMP (0.014–0.026 mg/mL), with correlation coefficients exceeding 0.998 and RSD% not exceeding 1.06%. The method’s greenness was evaluated using AGREE and GAPI tools. Additionally, the Blue Applicability Grade Index (BAGI) was employed to assess operational and environmental suitability. Results: The method exhibited high accuracy, reproducibility, and compliance with green analytical chemistry standards. The AGREE and GAPI assessments confirmed the method's minimal environmental impact. BAGI scoring yielded a value of 82.5, indicating strong sustainability and applicability. The method was successfully applied to the analysis of 13 commercial antidiabetic products, including branded and generic formulations available in the Iraqi market. Conclusion: The developed HPLC method provides a reliable, accurate, and environmentally sustainable approach for the simultaneous analysis of MET, STG, and EMP. It demonstrates strong analytical performance and practical utility, contributing to green pharmaceutical quality control and sustainable laboratory practices.

Medical Forum MonthlyVol. 36(3)
Openalex Percentile: Top 85%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.